Research database

SVF Research Library

Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 56 matching records.

Search the database

Evidence

Sort

56 results — page 1 of 3

Level CRetrospective StudyEurope PMC
Periorbital Changes Following Glucagon-Like Peptide-1 Receptor Agonist Use: A Retrospective Cohort Study of Oculofacial Complications and Interventions
Retrospective Study on Type 2 Diabetes, Skin Aging, published in Ophthalmic Plast Reconstr Surg (2026) — summary generated from the PubMed abstract.
2026
Ophthalmic Plast Reconstr Surg
Level DNarrative ReviewPubMed
Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes.
Narrative Review on Type 2 Diabetes, Chronic Wound, Skin Aging, published in J Clin Med (2026) — summary generated from the PubMed abstract.
2026
J Clin Med
Level DNarrative ReviewPubMed
Poly-l-Lactic Acid as a Regenerative Treatment for the Glucagon-like Peptide-1 Receptor Agonist User Population.
Narrative Review on Skin Aging, published in Dermatol Surg (2026) — summary generated from the PubMed abstract.
2026
Dermatol Surg
Level DAnimal StudyPubMed
Oat beta-glucan inhibited obesity in mice though stem cell remodeling.
Animal Study, published in Int J Biol Macromol (2025) — summary generated from the PubMed abstract.
2025
Int J Biol Macromol
3 citations
Level DNarrative ReviewEurope PMC
Glucagon-like peptide-1: a new potential regulator for mesenchymal stem cells in the treatment of type 2 diabetes mellitus and its complication
Narrative Review on Type 2 Diabetes, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
2025
Stem Cell Res Ther
3 citations
Level DNarrative ReviewPubMed
Tissue Regeneration of Radiation-Induced Skin Damages Using Protein/Polysaccharide-Based Bioengineered Scaffolds and Adipose-Derived Stem Cells: A Review.
Narrative Review on Chronic Wound, Scar, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
2025
Int J Mol Sci
6 citations
Level DNarrative ReviewEurope PMC
Adipose Tissue, at the Core of the Action of Incretin and Glucagon-Based Anti-Obesity Drugs
Narrative Review on Systemic / IV, published in Curr Obes Rep (2025) — summary generated from the PubMed abstract.
2025
Curr Obes Rep
5 citations
Level DNarrative ReviewEurope PMC
Effects of Glucagon-Like Peptide-1 receptor agonists on bone health in people living with obesity
Narrative Review, published in Osteoporos Int (2025) — summary generated from the PubMed abstract.
2025
Osteoporos Int
1 citations
Level BClinical TrialEurope PMC
Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
Clinical Trial on Hair Loss, published in Cureus (2025) — summary generated from the PubMed abstract.
2025
Cureus
1 citations
Level DNarrative ReviewEurope PMC
Dermatologic Implications of Glucagon-Like Peptide-1 Receptor Agonist Medications
Narrative Review on Type 2 Diabetes, Chronic Wound, Hair Loss, published in Skin Appendage Disord (2025) — summary generated from the PubMed abstract.
2025
Skin Appendage Disord
21 citations
Level DLaboratory StudyEurope PMC
A comprehensive summary of the GISM annual meeting 2025
Laboratory Study, published in Extracell Vesicles Circ Nucl Acids (2025) — summary generated from the PubMed abstract.
2025
Extracell Vesicles Circ Nucl Acids
Level CProspective StudyEurope PMC
Mechanisms of Glucagon-Like Peptide 1 Receptor Agonist-Induced Facial Lipodystrophy and a Path Toward Prevention
Prospective Study on Face & Skin, Systemic / IV, published in J Cosmet Dermatol (2025) — summary generated from the PubMed abstract.
2025
J Cosmet Dermatol
4 citations
Level DAnimal StudyEurope PMC
Anatomical implant region - a critical determinant for the osteogenic potency of small extracellular vesicles and rhBMP-2
Animal Study, published in Eur J Trauma Emerg Surg (2025) — summary generated from the PubMed abstract.
2025
Eur J Trauma Emerg Surg
Level DNarrative ReviewEurope PMC
Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Narrative Review, published in Diabetes Metab J (2024) — summary generated from the PubMed abstract.
2024
Diabetes Metab J
81 citations
Level BClinical TrialEurope PMC
Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges
Clinical Trial on Type 2 Diabetes, published in World J Hepatol (2024) — summary generated from the PubMed abstract.
2024
World J Hepatol
13 citations
Level DNarrative ReviewPubMed
Decoding the Implications of Glucagon-like Peptide-1 Receptor Agonists on Accelerated Facial and Skin Aging.
Narrative Review on Skin Aging, published in Aesthet Surg J (2024) — summary generated from the PubMed abstract.
2024
Aesthet Surg J
23 citations
Level DNarrative ReviewEurope PMC
Lesson on obesity and anatomy of adipose tissue: new models of study in the era of clinical and translational research
Narrative Review, published in J Transl Med (2024) — summary generated from the PubMed abstract.
2024
J Transl Med
10 citations
Level CProspective StudyEurope PMC
The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk
Prospective Study on Type 2 Diabetes, published in Nat Commun (2024) — summary generated from the PubMed abstract.
2024
Nat Commun
13 citations
Level BClinical TrialEurope PMC
Clinical Impact of Glucagon-Like Peptide-1 Receptor Analogs on the Complications of Obesity
Clinical Trial on Osteoarthritis, published in Obes Facts (2023) — summary generated from the PubMed abstract.
2023
Obes Facts
13 citations
Level DAnimal StudyPubMed
Culture and Differentiation of Primary Preadipocytes from Mouse Subcutaneous White Adipose Tissue.
Animal Study, published in Methods Mol Biol (2023) — summary generated from the PubMed abstract.
2023
Methods Mol Biol
3 citations
Level DLaboratory StudyEurope PMC
Regulation of Human Sortilin Alternative Splicing by Glucagon-like Peptide-1 (GLP1) in Adipocytes
Laboratory Study on Type 2 Diabetes, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
2023
Int J Mol Sci
2 citations
Level DAnimal StudyEurope PMC
Glucagon receptor signaling at white adipose tissue does not regulate lipolysis
Animal Study on Type 2 Diabetes, published in Am J Physiol Endocrinol Metab (2022) — summary generated from the PubMed abstract.
2022
Am J Physiol Endocrinol Metab
28 citations
Level DLaboratory StudyPubMed
Physicochemical changes of the chitosan/β-1,3-glucan/hydroxyapatite biocomposite caused by mesenchymal stem cells cultured on its surface in vitro.
Laboratory Study on Face & Skin, published in Spectrochim Acta A Mol Biomol Spectrosc (2021) — summary generated from the PubMed abstract.
2021
Spectrochim Acta A Mol Biomol Spectrosc
1 citations
Level DAnimal StudyEurope PMC
Nanostructured Cellulose-Gellan-Xyloglucan-Lysozyme Dressing Seeded with Mesenchymal Stem Cells for Deep Second-Degree Burn Treatment
Animal Study on Chronic Wound, Burns, Scar, published in Int J Nanomedicine (2021) — summary generated from the PubMed abstract.
2021
Int J Nanomedicine
18 citations

In-depth reviewed studies (full Thai translation)

Evidence system

SVF Research Library

Periorbital Changes Following Glucagon-Like Peptide-1 Receptor Agonist Use: A Retrospective Cohort Study of Oculofacial Complications and Interventions

Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes.

Poly-l-Lactic Acid as a Regenerative Treatment for the Glucagon-like Peptide-1 Receptor Agonist User Population.

Oat beta-glucan inhibited obesity in mice though stem cell remodeling.

Glucagon-like peptide-1: a new potential regulator for mesenchymal stem cells in the treatment of type 2 diabetes mellitus and its complication

Tissue Regeneration of Radiation-Induced Skin Damages Using Protein/Polysaccharide-Based Bioengineered Scaffolds and Adipose-Derived Stem Cells: A Review.

Adipose Tissue, at the Core of the Action of Incretin and Glucagon-Based Anti-Obesity Drugs

Effects of Glucagon-Like Peptide-1 receptor agonists on bone health in people living with obesity

Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review

Dermatologic Implications of Glucagon-Like Peptide-1 Receptor Agonist Medications

A comprehensive summary of the GISM annual meeting 2025

Mechanisms of Glucagon-Like Peptide 1 Receptor Agonist-Induced Facial Lipodystrophy and a Path Toward Prevention

Anatomical implant region - a critical determinant for the osteogenic potency of small extracellular vesicles and rhBMP-2

Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism

Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges

Decoding the Implications of Glucagon-like Peptide-1 Receptor Agonists on Accelerated Facial and Skin Aging.

Lesson on obesity and anatomy of adipose tissue: new models of study in the era of clinical and translational research

The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

Clinical Impact of Glucagon-Like Peptide-1 Receptor Analogs on the Complications of Obesity

Culture and Differentiation of Primary Preadipocytes from Mouse Subcutaneous White Adipose Tissue.

Regulation of Human Sortilin Alternative Splicing by Glucagon-like Peptide-1 (GLP1) in Adipocytes

Glucagon receptor signaling at white adipose tissue does not regulate lipolysis

Physicochemical changes of the chitosan/β-1,3-glucan/hydroxyapatite biocomposite caused by mesenchymal stem cells cultured on its surface in vitro.

Nanostructured Cellulose-Gellan-Xyloglucan-Lysozyme Dressing Seeded with Mesenchymal Stem Cells for Deep Second-Degree Burn Treatment

In-depth reviewed studies (full Thai translation)

Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial

Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials

Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis